Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Safety, efficacy, and therapeutic role of NSAIDs must be clarified
| The first 150 words of the full text of this article appear below. |
EDITOR
Moore et al concluded in their study that topical non-steroidal
anti-inflammatory drugs are better than placebo in acute and chronic
musculoskeletal pain.1 Does this help to define their role
in practice?
While we accept that these agents are better than placebo (this is considered during drug licensing), this does not help to decide how clinically effective they are. To define a therapeutic role for these preparations2 we need comparisons with other interventions, such as oral non-steroidal anti-inflammatory drugs, topical rubefacients, or paracetamol. Of the 87 trials reviewed by Moore et al only five compared topical with oral non-steroidal anti-inflammatory drugs, and none had adequate design or power to enable comparison.
We are also concerned about the methodology used in this review.
Moore et al conclude that the trials reviewed were of a good quality.
We recently reviewed this area and found that many trials had poor
methodology, low numbers